Announcements Trials

Browse Landscape

Phase

Phase 2/3 2 Phase NA 1 Phase 3 1 Phase 2 1

Status

Sponsor Class

OTHER 4 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Barrett Esophagus 1

Interventions

Carboplatin 314 Paclitaxel 302 Cisplatin 250 Docetaxel 237 pembrolizumab 230 Gemcitabine 213 Pemetrexed 158 Capecitabine 147 Rituximab 144 Bevacizumab 142 Dexamethasone 125 Fluorouracil 120 Cyclophosphamide 102 Trastuzumab 100 Doxorubicin 96 Nivolumab 92 Prednisone 91 Oxaliplatin 89 atezolizumab 73 Leucovorin 71 durvalumab 69 130-nm albumin-bound paclitaxel 67 Injections 64 Lenalidomide 63 Irinotecan 60 Bortezomib 55 Letrozole 54 Topotecan 53 Fulvestrant 53 Drug Therapy 50

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × INDUSTRY × Endoscopy × Clear all

NCT01209013 2012-05-08

Oedisse

Pinnacle Biologics Inc.

Phase 3 Withdrawn

Gastrointestinal

Barrett Esophagus

Data powered by HemOnc (CC BY 4.0) Colophon ⚡